Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
General Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Gastroenterologist
MBBS, MD (Gastroenterology), Fellowship in ERCP
Endocrinologist
M.B.B.S., F.C.P.S. (Endocrinologist), F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, Diploma in Public Health Management, Diploma in Health Psychology
Internal Medicine Specialist
MBBS, Diploma in Public Health Management, Diploma in Health Psychology
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures